Cantrell Drug Company Updates FDA Registration to 503B Outsourcing Facility
1/24/2014 10:35:54 AM
LITTLE ROCK, Ark.--(BUSINESS WIRE)--Cantrell Drug Company today announced amendment of its U.S. Food and Drug Administration (FDA) registration to include the new 503B “compounding outsourcing facility” designation established under the recently passed Drug Quality and Security Act so that it can continue to serve patients nationwide with sterile medications that meet the most exacting quality standards.
Help employers find you! Check out all the jobs and post your resume.
comments powered by